라인
왼쪽
오른쪽
> INDUSTRY > Bio

Samsung Medison’s diagnostic ultrasound imaging ‘Crystal Vue’ featured on the cover of Leading Academic Journal

Whowired News Team  |  press@whowired.com
폰트키우기 폰트줄이기 프린트하기 메일보내기 신고하기
승인 2016.03.30  09:05:57
트위터 페이스북 네이버 구글 msn
   

Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, announced that its latest imaging technology ‘Crystal Vue’ has been featured on the front cover of Ultrasound in Obstetrics & Gynecology (UOG), a renowned academic journal in the women’s healthcare industry and the official journal published by the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG).

The March edition of the UOG featured a clinical case study by Dr. Christoph Lees, professor at the Department of Surgery & Cancer within the Faculty of Medicine at Imperial College in London. Using Samsung’s premium diagnostic ultrasound system WS80A, professor Lees introduced two cases of prenatal imaging through Crystal Vue, of which the rib & vertebral images were selected as the Picture of the Month by UOG.

“Our experience with Crystal Vue over the past few months, specifically imaging of the bone and soft tissue interface, leads us to believe that it may offer new opportunities for prenatal imaging, particularly for the skeletal system, but also in facial and brain imaging,” Professor Lees stated in his study. “We were able to obtain highly detailed images that give particular information on the contour of the ribs and allow inference on mineralization.”

Crystal Vue is an advanced 3D volume rendering technology that enables users to assess detailed information of internal and external structures of the fetus or uterus and helps easily differentiate between the soft tissue and bone. With the additional morphological information, users may deepen their understanding of the patients and fetus.

Crystal Vue was first introduced at the 25th World Congress on Ultrasound in Obstetrics and Gynecology, held in Canada in October 2015, as the latest imaging function of the WS80A. The WS80A with Crystal Vue is currently available globally.

“We are thrilled that Samsung’s latest technology was recognized in a leading academic journal as a new diagnostic imaging that can provide more clinical values in women’s health,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “With Samsung’s leading display and software technology, we will continue to develop new features that can increase diagnosis confidence and contribute to women and fetal health.”

Whowired News Team의 다른기사 보기  
폰트키우기 폰트줄이기 프린트하기 메일보내기 신고하기
트위터 페이스북 네이버 구글 msn 뒤로가기 위로가기
이 기사에 대한 댓글 이야기 (0)
자동등록방지용 코드를 입력하세요!   
확인
- 200자까지 쓰실 수 있습니다. (현재 0 byte / 최대 400byte)
- 욕설등 인신공격성 글은 삭제 합니다. [운영원칙]
이 기사에 대한 댓글 이야기 (0)
Photo News
Most Read
New Launch
LG Breaks New Ground with 2017 SUPER UHD TV Lineup Feat...
LG Breaks New Ground with 2017 SUPER UHD TV Lineup Featuring Nano Cell Technology
Employing the most advanced color-enhancing LCD panel t...
Life & Culture
New high speed railway launched to win customer satisfaction

New high speed railway launched to win customer satisfaction

Those who travel by high speed tra...
Hyundai Motorsport Finalizes 2017 WRC Driver Line-up

Hyundai Motorsport Finalizes 2017 WRC Driver Line-up

Hyundai Motorsport has finalized i...
SISTAR to Livestream Showcase for 4th Mini Album on June 21

SISTAR to Livestream Showcase for 4th Mini Album on June 21

SISTAR has revealed that they are ...
About WhowiredRSSAdvertise with UsComplaintsPrivacy PolicyYouth Protection PolicyRejection of Email Collection
Socrates Bldg. 2nd fl., 1947, Nambusunwhan-ro, Kwanak-gu, Seoul, 151-812 Republic of Korea
E-mail : press@whowired.com  |  TEL : 82 2 557 7313  |  Periodical Registration Number : Seoul AH 03117
Publisher : Song, Kyung-mi  |  Editor : Won, Cheol-rin  |   Youth Protection Policy : Kim, Jong-yoon |  FAX : 82 2 557 7312
Copyright © 2017 Whowired. All rights reserved.
As far as you expressly display the source of "Whowired" in your postings, any republishing or redisstribution will be allowed.